GlassScriptPhysician profile
Josef T Prchal
NPI 1427008341
$48,271.57
in general payments reported to CMS, 2019-2025
13 companies · $4,760 in 2025
The $4,760 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,929 · 2021: $2,554 · 2022: $7,536 · 2023: $23K · 2024: $1,877 · 2025: $4,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $11K · Consulting Fee: $9,064 · Travel and Lodging: $8,594 · Food and Beverage: $951 · Education: $42.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,600.00 |
| Consulting Fee | $9,064.46 |
| Travel and Lodging | $8,594.49 |
| Food and Beverage | $951.07 |
| Education | $42.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmaessentia USA Corporation | $21,071.99 | 2022-2024 | Besremi |
| Agios Pharmaceuticals, INC. | $7,328.92 | 2019-2023 | Pyrukynd |
| Glaxosmithkline, LLC. | $7,290.99 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $4,489.10 | 2025 | |
| Cti Biopharma Corp. | $3,200.00 | 2023 | Vonjo |
| Abbvie INC. | $2,200.00 | 2021 | |
| Celgene Corporation | $1,642.84 | 2019 | |
| Sobi, INC | $343.90 | 2024-2025 | |
| Pharmacosmos Therapeutics INC. | $243.16 | 2021 | |
| Incyte Corporation | $140.00 | 2025 | Jakafi |
| Karyopharm Therapeutics INC. | $120.30 | 2022 | |
| Rigel Pharmaceuticals, INC. | $110.54 | 2021 | |
| Apellis Pharmaceuticals, INC. | $89.83 | 2023 | Empaveli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josef Prchal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.